Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Experimental Medicine
|
October 5, 2016
UNG protects B cells from AID-induced telomere loss
Elena M Cortizas, Astrid Zahn, Shiva Safavi, et al.
Acta Neurologica Scandinavica
|
March 10, 2001
Anti-GM1 and anti-sulfatide antibodies in polyneuropathies. Threshold titers and accuracy
G Isoardo, B Ferrero, P Barbero, et al.
Genes & Development
|
February 5, 2026
Bypass of blocking lesions by RNAPII reveals a novel stress induced by DNA damage
Carolina P Bañuelos, Lucas D Caeiro, Pradeepkumar R Cingaram, et al.
Science Advances
|
June 18, 2020
Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer
Yusheng Zhang, Ho Lam Chan, Liliana Garcia-Martinez, et al.
Journal of the Neurological Sciences
|
November 1, 1996
Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis
M R Bongioanni, L Durelli, B Ferrero, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2025
Bypass of Blocking Lesions by RNAPII Impairs the Transcriptional DNA Damage Response
Carolina P Bañuelos, Lucas D Caeiro, Pradeepkumar R Cingaram, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 1, 1995
Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function
L Durelli, M R Bongioanni, R Cavallo, et al.
Journal of the Neurological Sciences
|
November 24, 2001
Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study
L Durelli, A Oggero, E Verdun, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 18, 2001
Interferon-beta dose and efficacy: the OPTIMS study
L Durelli, A Oggero, E Verdun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 24, 2022
LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage
Kerri-Ann Latchmansingh, Xiaoqiong Wang, Ramiro E Verdun, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Experimental Medicine
|
October 5, 2016
UNG protects B cells from AID-induced telomere loss
Elena M Cortizas, Astrid Zahn, Shiva Safavi, et al.
Acta Neurologica Scandinavica
|
March 10, 2001
Anti-GM1 and anti-sulfatide antibodies in polyneuropathies. Threshold titers and accuracy
G Isoardo, B Ferrero, P Barbero, et al.
Genes & Development
|
February 5, 2026
Bypass of blocking lesions by RNAPII reveals a novel stress induced by DNA damage
Carolina P Bañuelos, Lucas D Caeiro, Pradeepkumar R Cingaram, et al.
Science Advances
|
June 18, 2020
Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer
Yusheng Zhang, Ho Lam Chan, Liliana Garcia-Martinez, et al.
Journal of the Neurological Sciences
|
November 1, 1996
Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis
M R Bongioanni, L Durelli, B Ferrero, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2025
Bypass of Blocking Lesions by RNAPII Impairs the Transcriptional DNA Damage Response
Carolina P Bañuelos, Lucas D Caeiro, Pradeepkumar R Cingaram, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 1, 1995
Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function
L Durelli, M R Bongioanni, R Cavallo, et al.
Journal of the Neurological Sciences
|
November 24, 2001
Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study
L Durelli, A Oggero, E Verdun, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 18, 2001
Interferon-beta dose and efficacy: the OPTIMS study
L Durelli, A Oggero, E Verdun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 24, 2022
LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage
Kerri-Ann Latchmansingh, Xiaoqiong Wang, Ramiro E Verdun, et al.
Page
of 6